1
|
Thiraporn A, Saikachain N, Khumjiang R, Muanprasat C, Tadpetch K. Total Synthesis and Biological Evaluation of Mutolide and Analogues. Chem Asian J 2022; 17:e202200329. [PMID: 35727893 DOI: 10.1002/asia.202200329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2022] [Revised: 06/20/2022] [Indexed: 11/07/2022]
Abstract
The convergent total syntheses of three 14-membered macrolide natural products, mutolide, nigrosporolide and (4S,7S,13S)-4,7-dihydroxy-13-tetradeca-2,5,8-trienolide have been achieved. The key synthetic features include Shiina macrolactonization to assemble the 14-membered macrocyclic core, Wittig or Still-Gennari olefination and selective reduction of propargylic alcohol to construct the E- or Z-olefins. Cross metathesis was also highlighted as an efficient tool to forge the formation of E-olefin. The three synthetic macrolides were evaluated for their cytotoxic activity against three human cancer cell lines as well as for inhibitory effect on CFTR-mediated chloride secretion in human intestinal epithelial (T84) cells. Mutolide displayed significant cytotoxic activity against HCT116 colon cancer cells with an IC50 of ∼12 μM as well as a potent CTFR inhibitory effect with an IC50 value of ∼1 μM.
Collapse
Affiliation(s)
- Aticha Thiraporn
- Division of Physical Science and Center of Excellence for Innovation in Chemistry, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla, 90110, Thailand
| | - Nongluk Saikachain
- Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bang Pla, Bang Pli, Samut Prakan, 10540, Thailand
| | - Rungtiwa Khumjiang
- Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bang Pla, Bang Pli, Samut Prakan, 10540, Thailand
| | - Chatchai Muanprasat
- Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bang Pla, Bang Pli, Samut Prakan, 10540, Thailand
| | - Kwanruthai Tadpetch
- Division of Physical Science and Center of Excellence for Innovation in Chemistry, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla, 90110, Thailand
| |
Collapse
|
2
|
Paul D, Saha S, Goswami RK. Total Synthesis of Pestalotioprolide E and Structural Revision of Pestalotioprolide F. Org Lett 2018; 20:4606-4609. [DOI: 10.1021/acs.orglett.8b01894] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Debobrata Paul
- Department of Organic Chemistry, Indian Association for the Cultivation of Science, Jadavpur, Kolkata-700032, India
| | - Sanu Saha
- Department of Organic Chemistry, Indian Association for the Cultivation of Science, Jadavpur, Kolkata-700032, India
| | - Rajib Kumar Goswami
- Department of Organic Chemistry, Indian Association for the Cultivation of Science, Jadavpur, Kolkata-700032, India
| |
Collapse
|
3
|
Bhadra PK, Hassanzadeh A, Arsic B, Allison DG, Morris GA, Barber J. Enhancement of the properties of a drug by mono-deuteriation: reduction of acid-catalysed formation of a gut-motilide enol ether from 8-deuterio-erythromycin B. Org Biomol Chem 2016; 14:6289-96. [DOI: 10.1039/c6ob00785f] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
An efficient synthesis of 8-d-erythromycin B was achieved. A deuterium isotope effect suppresses formation of the corresponding enol ether, which may result in reduced gut-motilide effects.
Collapse
Affiliation(s)
| | | | - Biljana Arsic
- Manchester Pharmacy School
- University of Manchester
- Manchester
- UK
| | | | | | - Jill Barber
- Manchester Pharmacy School
- University of Manchester
- Manchester
- UK
| |
Collapse
|
4
|
Tadpetch K, Jeanmard L, Rukachaisirikul V. Total synthesis of the proposed structure of pestalotioprolide A. ACTA ACUST UNITED AC 2015. [DOI: 10.1016/j.tetasy.2015.06.020] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
5
|
Tarran R, Sabater JR, Clarke TC, Tan CD, Davies CM, Liu J, Yeung A, Garland AL, Stutts MJ, Abraham WM, Phillips G, Baker WR, Wright CD, Wilbert S. Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion. Am J Physiol Lung Cell Mol Physiol 2013; 304:L746-56. [PMID: 23542952 DOI: 10.1152/ajplung.00292.2012] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
Mucus clearance is an important component of the lung's innate defense system. A failure of this system brought on by mucus dehydration is common to both cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). Mucus clearance rates are regulated by the volume of airway surface liquid (ASL) and by ciliary beat frequency (CBF). Chronic treatment with macrolide antibiotics is known to be beneficial to both CF and COPD patients. However, chronic macrolide usage may induce bacterial resistance. We have developed a novel macrolide, 2'-desoxy-9-(S)-erythromycylamine (GS-459755), that has significantly diminished antibiotic activity against Staphylococcus aureus, Streptococcus pneumonia, Moraxella catarrhalis, and Haemophilus influenzae. Since neutrophilia frequently occurs in chronic lung disease and human neutrophil elastase (HNE) induces mucus stasis by activating the epithelial sodium channel (ENaC), we tested the ability of GS-459755 to protect against HNE-induced mucus stasis. GS-459755 had no effect on HNE activity. However, GS-459755 pretreatment protected against HNE-induced ASL volume depletion in human bronchial epithelial cells (HBECs). The effect of GS-459755 on ASL volume was dose dependent (IC₅₀ ~3.9 μM) and comparable to the antibacterial macrolide azithromycin (IC₅₀ ~2.4 μM). Macrolides had no significant effect on CBF or on transepithelial water permeability. However, the amiloride-sensitive transepithelial voltage, a marker of ENaC activity, was diminished by macrolide pretreatment. We conclude that GS-459755 may limit HNE-induced activation of ENaC and may be useful for the treatment of mucus dehydration in CF and COPD without inducing bacterial resistance.
Collapse
Affiliation(s)
- Robert Tarran
- Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina, Chapel Hill, NC 27516, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Ma S, Jiao B, Ju Y, Zheng M, Ma R, Liu L, Zhang L, Shen X, Ma C, Meng Y, Wang H, Qi Y, Ma X, Cui W. Synthesis and antibacterial evaluation of novel clarithromycin derivatives with C-4″ elongated arylalkyl groups against macrolide-resistant strains. Eur J Med Chem 2010; 46:556-66. [PMID: 21159410 DOI: 10.1016/j.ejmech.2010.11.035] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2010] [Revised: 11/18/2010] [Accepted: 11/18/2010] [Indexed: 10/18/2022]
Abstract
Novel clarithromycin derivatives with C-4″ elongated arylalkyl groups were designed, synthesized and evaluated to probe the effect of different lengths of their C-4″ side chains on the activity against resistant bacterial strains. These derivatives had excellent activity against erythromycin-susceptible Streptococcus pneumoniae, Streptococcus aureus or Streptococcus pyogenes and some of them exhibited greatly improved activity against erythromycin-resistant strains. Compounds 18 and 16, which had the C-4″ elongated arylalkyl groups with eight atoms from the 4″-oxygen atom to the terminal benzene ring, were the most effective against S. pneumoniae expressing the erm gene and the erm and mef genes. In contrast, the most potent compounds 3, 5, 9, 17 and 18 against S. pneumoniae expressing the mef gene had C-4″ elongated arylalkyl groups with three to eight atoms between the 4″-oxygen atom and the terminal aromatic ring.
Collapse
Affiliation(s)
- Shutao Ma
- Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, 44 West Culture Road, Jinan 250012, PR China.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Andreotti D, Bientinesi I, Biondi S, Donati D, Erbetti I, Lociuro S, Marchioro C, Pozzan A, Ratti E, Terreni S. A novel ketolide class: Synthesis and antibacterial activity of a lead compound. Bioorg Med Chem Lett 2007; 17:5265-9. [PMID: 17681467 DOI: 10.1016/j.bmcl.2007.02.019] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2007] [Revised: 02/01/2007] [Accepted: 02/07/2007] [Indexed: 11/21/2022]
Abstract
Synthesis and antibacterial activity of a new class of ketolide antibiotics, exemplified by the prototype GW680788X (1), are described. The structure of (1) has been elucidated by spectroscopic analysis. The good antibacterial activity shown by (1) in comparison with clarithromycin prompted us to consider this compound as a lead molecule for further exploration.
Collapse
Affiliation(s)
- Daniele Andreotti
- GlaxoSmithKline, Medicine Research Centre, Via A Fleming 4, I-37135 Verona, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Zhou CC, Huang X, Ford KL, Hollis LS. Isolation and identification of a novel impurity of erythromycin A 9-oxime desosaminehydrazinium salt. J Antibiot (Tokyo) 2005; 58:539-44. [PMID: 16266129 DOI: 10.1038/ja.2005.75] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
In the manufacturing process for Biaxin (clarithromycin), erythromycin-A oxime, an intermediate, is obtained in high yield, when erythromycin-A is treated with hydroxylamine/isopropyl alcohol in the presence of acetic acid. An unusual impurity, the desosamine hydrazinium salt, is generated in this step of the synthetic pathway, and has been isolated and characterized by using one and two-dimensional NMR spectroscopy in conjunction with MS and EDS.
Collapse
|
9
|
Abstract
Research in the field of macrolide antibiotics has continued. The aims of research efforts are quite different with 14-, 15- and 16-membered ring macrolides. A review of 14- and 15-membered ring macrolides covering the period up to 1995 was published in a previous issue of this journal.
Collapse
Affiliation(s)
- A Bryskier
- Hoechst Marion Roussel, 102 Route de Noisy, 93230 Romainville Cedex, France
| |
Collapse
|
10
|
|
11
|
Beebe X, Yang F, Bui MH, Mitten MJ, Ma Z, Nilius AM, Djuric SW. Synthesis and antibacterial activity of 6-O-arylpropargyl-9-oxime-11,12-carbamate ketolides. Bioorg Med Chem Lett 2004; 14:2417-21. [PMID: 15109624 DOI: 10.1016/j.bmcl.2004.03.020] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2004] [Revised: 02/27/2004] [Accepted: 03/08/2004] [Indexed: 10/26/2022]
Abstract
A series of novel 6-O-arylpropargyl-9-oxime-ketolides was synthesized and evaluated against various pathogens. These new compounds show promising in vitro antibacterial potency and in vivo efficacy against macrolide resistant strains.
Collapse
Affiliation(s)
- Xenia Beebe
- Infectious Disease Research, Abbott Laboratories, Abbott Park, IL 60064, USA.
| | | | | | | | | | | | | |
Collapse
|
12
|
Pandey D, Katti SB, Haq W, Tripathi CKM. Synthesis and antimicrobial activity of erythromycin-A oxime analogs. Bioorg Med Chem 2004; 12:3807-13. [PMID: 15210147 DOI: 10.1016/j.bmc.2004.05.011] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2004] [Accepted: 05/08/2004] [Indexed: 11/23/2022]
Abstract
A series of erythromycin-A oxime ether as well as esters have been synthesized. Ether derivatives were synthesized through the epoxy ether intermediate of erythromycin-9-oxime, followed by opening of the epoxy linkage through various amines, whereas esters have been prepared through DCC mediated protocol. These derivatives have been evaluated for antibacterial activity and found to be as active as erythromycin-A.
Collapse
Affiliation(s)
- Deepa Pandey
- Division of Medicinal Chemistry, Central Drug Research Institute, Lucknow 226001, India
| | | | | | | |
Collapse
|
13
|
Hunfeld KP, Wichelhaus TA, Rödel R, Acker G, Brade V, Kraiczy P. Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi. Antimicrob Agents Chemother 2004; 48:344-7. [PMID: 14693564 PMCID: PMC310164 DOI: 10.1128/aac.48.1.344-347.2004] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Two ketolides, three macrolides, and one azalide were tested in vitro against 17 isolates of the B. burgdorferi s.l. complex. As measured in micrograms per milliliter, activity was highest for cethromycin (MIC at which 90% of the tested isolates were inhibited [MIC(90)], 0.0019 micro g/ml) and telithromycin (MIC(90), 0.0078 micro g/ml). Electron-microscope analysis and time-kill studies also supported enhanced effectiveness of both ketolides.
Collapse
Affiliation(s)
- Klaus-Peter Hunfeld
- Institute of Medical Microbiology, University Hospital of Frankfurt, D-60596 Frankfurt/Main, Germany.
| | | | | | | | | | | |
Collapse
|
14
|
Drysdale MJ, Lentzen G, Matassova N, Murchie AIH, Aboul-Ela F, Afshar M. RNA as a drug target. PROGRESS IN MEDICINAL CHEMISTRY 2003; 39:73-119. [PMID: 12536671 DOI: 10.1016/s0079-6468(08)70069-9] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
In the antiviral and antibacterial area, increasing drug resistance means that there is an ever growing need for novel approaches towards structures and mechanisms which avoid the current problems. The huge increase in high resolution structural data is set to make a dramatic impact on targeting RNA as a drug target. The examples of the RNA binding antibiotics, particularly, the totally synthetic oxazolidinones, should help persuade the skceptics that clinically useful, selective drugs can be obtained from targeting RNA directly.
Collapse
Affiliation(s)
- Martin J Drysdale
- Department of Chemistry, RiboTargets Ltd., Granta Park, Abington, Cambridge, CB1 6GB, UK
| | | | | | | | | | | |
Collapse
|
15
|
Kerdesky FAJ, Premchandran R, Wayne GS, Chang SJ, Pease JP, Bhagavatula L, Lallaman JE, Arnold WH, Morton HE, King SA. Synthesis of 2‘-O-Benzoyl-3-keto-6-O-propargyl-11,12-carbamoyl Erythromycin A. Org Process Res Dev 2002. [DOI: 10.1021/op025535m] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Francis A. J. Kerdesky
- Department R450, Global Pharmaceutical Research & Development, Abbott Laboratories, 1401 Sheridan Road, North Chicago, Illinois 60064-6285, U.S.A
| | - Ramiya Premchandran
- Department R450, Global Pharmaceutical Research & Development, Abbott Laboratories, 1401 Sheridan Road, North Chicago, Illinois 60064-6285, U.S.A
| | - Gregory S. Wayne
- Department R450, Global Pharmaceutical Research & Development, Abbott Laboratories, 1401 Sheridan Road, North Chicago, Illinois 60064-6285, U.S.A
| | - Sou-Jen Chang
- Department R450, Global Pharmaceutical Research & Development, Abbott Laboratories, 1401 Sheridan Road, North Chicago, Illinois 60064-6285, U.S.A
| | - Jonathan P. Pease
- Department R450, Global Pharmaceutical Research & Development, Abbott Laboratories, 1401 Sheridan Road, North Chicago, Illinois 60064-6285, U.S.A
| | - Lakshmi Bhagavatula
- Department R450, Global Pharmaceutical Research & Development, Abbott Laboratories, 1401 Sheridan Road, North Chicago, Illinois 60064-6285, U.S.A
| | - John E. Lallaman
- Department R450, Global Pharmaceutical Research & Development, Abbott Laboratories, 1401 Sheridan Road, North Chicago, Illinois 60064-6285, U.S.A
| | - William H. Arnold
- Department R450, Global Pharmaceutical Research & Development, Abbott Laboratories, 1401 Sheridan Road, North Chicago, Illinois 60064-6285, U.S.A
| | - Howard E. Morton
- Department R450, Global Pharmaceutical Research & Development, Abbott Laboratories, 1401 Sheridan Road, North Chicago, Illinois 60064-6285, U.S.A
| | - Steven A. King
- Department R450, Global Pharmaceutical Research & Development, Abbott Laboratories, 1401 Sheridan Road, North Chicago, Illinois 60064-6285, U.S.A
| |
Collapse
|
16
|
Abstract
ABT-773 is a new semisynthetic derivative of erythromycin A, the ketolide class of broad spectrum antibacterial agents, in Phase II development by Abbott. With good broad spectrum activity against Gram-positive, some Gram-negative organisms and intracellular bacteria, ABT-773 is being developed as a respiratory agent. Structural changes in the ketolide class agents such as ABT-773 provides expanded activity in vitro against macrolide-resistant strains of Streptococcus pneumoniae and improved activity against MLS(B) (macrolide-lincosamide-streptogramin) constitutive expressing streptococci.
Collapse
Affiliation(s)
- T J Dougherty
- Bristol-Myers Squibb Pharmaceutical Research Institute, Department of Microbiology, 5 Research Parkway, Wallingford, CT 06492, USA
| | | |
Collapse
|
17
|
Clark RF, Ma Z, Wang S, Griesgraber G, Tufano M, Yong H, Li L, Zhang X, Nilius AM, Chu DT, Or YS. Synthesis and antibacterial activity of novel 6-O-substituted erythromycin A derivatives. Bioorg Med Chem Lett 2000; 10:815-9. [PMID: 10782693 DOI: 10.1016/s0960-894x(00)00106-2] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
A series of novel 6-O-substituted erythromycin A derivatives has been synthesized. Good in vitro antibacterial activity has been demonstrated for analogues incorporating a variety of structural features. The methodology disclosed is expected to find application in the design of future macrolide antibiotics that target the prevalent bacterial resistance problem.
Collapse
Affiliation(s)
- R F Clark
- Infectious Diseases Research, Abbott Laboratories, Abbott Park, IL 60064-3537, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 1999; 43:2823-30. [PMID: 10582867 PMCID: PMC89572 DOI: 10.1128/aac.43.12.2823] [Citation(s) in RCA: 580] [Impact Index Per Article: 23.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- M C Roberts
- Department of Pathobiology, University of Washington, Seattle, Washington 98195, USA.
| | | | | | | | | | | |
Collapse
|
19
|
McDaniel R, Thamchaipenet A, Gustafsson C, Fu H, Betlach M, Ashley G. Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel "unnatural" natural products. Proc Natl Acad Sci U S A 1999; 96:1846-51. [PMID: 10051557 PMCID: PMC26699 DOI: 10.1073/pnas.96.5.1846] [Citation(s) in RCA: 323] [Impact Index Per Article: 12.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
The structures of complex polyketide natural products, such as erythromycin, are programmed by multifunctional polyketide synthases (PKSs) that contain modular arrangements of functional domains. The colinearity between the activities of modular PKS domains and structure of the polyketide product portends the generation of novel organic compounds-"unnatural" natural products-by genetic manipulation. We have engineered the erythromycin polyketide synthase genes to effect combinatorial alterations of catalytic activities in the biosynthetic pathway, generating a library of >50 macrolides that would be impractical to produce by chemical methods. The library includes examples of analogs with one, two, and three altered carbon centers of the polyketide products. The manipulation of multiple biosynthetic steps in a PKS is an important milestone toward the goal of producing large libraries of unnatural natural products for biological and pharmaceutical applications.
Collapse
Affiliation(s)
- R McDaniel
- KOSAN Biosciences, Inc., 1450 Rollins Road, Burlingame, CA 94010, USA.
| | | | | | | | | | | |
Collapse
|
20
|
Elliott RL, Pireh D, Nilius AM, Johnson PM, Flamm RK, Chu DT, Plattner JJ, Or YS. Novel 3-deoxy-3-descladinosyl-6-O-methyl erythromycin a analogues. Synthesis and in vitro activity. Bioorg Med Chem Lett 1997. [DOI: 10.1016/s0960-894x(97)00078-4] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
21
|
Chapter 13. Antibacterial Agents. ANNUAL REPORTS IN MEDICINAL CHEMISTRY 1996. [DOI: 10.1016/s0065-7743(08)60452-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register]
|